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Figure 1: (a) Example transverse slice through the liver of an 
XCAT attenuation phantom, and (b) the corresponding slice 
from the simulated image set. 
 
Conclusion: Image processing applied to XCAT attenuation 
coefficient phantoms has been used to simulate features 
observable in patient 4DCT image sets. The image processing 
technique is time and resource efficient and does not require 
generation of simulated projection images and 3D 
reconstruction. 
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Purpose or Objective: A Varian TrueBeam with OBI was 
commissioned in 2014. During early clinical use concerns 
were raised regarding thoracic CBCT image quality in 
comparison with that observed in Elekta XVI images. 
Streaking artefacts caused by respiratory motion were the 
primary reason for the perceived poor quality. This study 
compared the image quality of the TrueBeam OBI with the 
other CBCT systems at the centre, a Varian Trilogy OBI and 
Elekta XVI, using quantitative and qualitative methods. 
 
Material and Methods: A static Catphan phantom (The 
Phantom Laboratory) was used to assess image quality 
quantitatively, and to create a HU calibration curve for the 
XVI. 
A Quasar phantom (Modus Medical Systems) with moving 
inserts was used to investigate the effect of motion on CBCT 
image quality. A systematic pattern of motion artefacts was 
revealed. Artefacts (created by a high density object moving 
along the axis perpendicular to the slice) were assessed in an 
axial slice. Circular profiles were used to quantify the 
artefacts on the three systems. 
Clinical image quality was assessed through a qualitative 
study where two experienced observers independently scored 
24 randomly selected clinical thoracic CBCT scans (8 per 
system). CBCT images were viewed alongside the planning CT 
scan, with the PTV outline being the only visible delineated 
structure. Scoring was based on a five point scale and 
reflected the image quality for matching purposes, the 
clinical task. Eight anatomical regions, sharpness, contrast, 
impact of artefacts, and the overall image quality were 
scored. Comments were also recorded. 
 
Results: Quantitative assessment using the Catphan revealed 
no differences between systems that was deemed significant. 
The variation in magnitude of the streaking artefacts in the 
Quasar phantom was found to depend on scan time, but not 
on the system, as shown in Table 1. 
 
 
 
The Mann-Whitney test was applied to each observer’s scores 
for each metric of the clinical image analysis. No significant 
(p<0.05) differences between any systems for any metric for 
either user were detected. 
  
 
 
Conclusion: Investigations to date indicate no significant 
difference between the systems assessed. Image quality must 
allow matching of the CBCT to CT with confidence. Staff 
were thus reassured that all systems were assessed as 
“acceptable” (mean score of 3) for most metrics. It was felt 
that patient size was often the cause of particularly good or 
poor scores; therefore improvement of patient size 
dependent protocols is identified as a key area of future 
work. 
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Purpose or Objective: PET/MRI may be highly beneficial for 
radiotherapy planning (RTP) in head and neck (HN) cancer in 
terms of increased accuracy in target volume definition (TVD) 
and integration of functional tissue properties. As the 
integration of imaging data into RTP requires co-registration, 
PET/MR examination in RT treatment position is favorable. 
Therefore, we propose a solution using a dedicated hardware 
setup.  
Moreover, accuracy of TVD depends on the spatial accuracy 
of the imaging data. Since diffusion-weighted MR imaging 
(DWI) based on echo planar imaging (EPI) is prone to spatial 
inaccuracy, the aim of this study was to evaluate the quality 
of DWI with RT scan setup using dedicated distortion 
correction. 
 
Material and Methods: The RT hardware setup consists of a 
flat table overlay and two coil holders for flexible body 
matrix coils (Siemens mMR), in addition to an in-house 
designed overlay add-on for RT mask fixation (cf. Fig1).  
The evaluation of DWI quality using the RT setup was based 
on MR-only scans of n=3 healthy volunteers. Each time, two 
scans were performed: (I) using the RT setup with a pair of 6-
channel flexible RF coils, (II) a reference scan, using a 
standard 16-channel HN coil. The protocol included T2w 
SPACE, T2w TSE, and DWI (b = 150 and 800 s/mm2).  
DWI data was collected with reversed phase encode blips in 
order to use a correction method for susceptibility-induced 
distortions as implemented in the open source toolkit FSL.  
The geometric accuracy of DWI was assessed on a ROI basis 
by comparing pairwise distortion corrected and uncorrected 
b150 images to T2w images. Four ROIs were placed in 
submandibular glands and cervical spine. In addition to 
spatial distances between ROI centers, the Dice similarity 
index (DSI) was calculated to assess ROI similarity.  
Furthermore, ADC values derived from ROIs of the corrected 
b150 images were compared between RT and reference 
scans.  
One set of DW images acquired with RT setup had to be 
excluded from analysis due to strong MR image artifacts. 
 
Results: DWI suffered from geometric distortions with both 
scan setups but correction with FSL led to significantly 
reduced effects. These were of the same order as differences 
in ROI delineation between T2w images due to minor 
involuntary patient motion. The average displacements of the 
ROIs' centers of mass between DW and T2w images were 
4.6±2.3 mm / 5.9±3.4 mm (RT / REF) and 1.0±0.4 mm / 
1.5±0.9 mm for standard DWI and distortion corrected DWI, 
respectively (cf. Fig2 A). Fig2 B presents the average DSI per 
ROI pair: 0.4±0.1 / 0.4±0.2 (RT / REF) and 0.8±0 / 0.7±0.1, 
accordingly.  
ADC values differed by 7±14% on average comparing the RT 
with the standard coil setup. 
 
Conclusion: The presented PET/MR hardware solution for HN 
imaging enables for RT-specific patient positioning. Using 
dedicated correction methods, spatial distortions in DWI can 
be significantly reduced allowing for accurate usage of DWI in 
RTP. ADC values of distortion corrected maps of the RT scan 
setup were found to be adequate. 
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Purpose or Objective: New treatment modalities are 
developed with the aim of escalating tumor absorbed dose 
